Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsStem CellsGraft vs Host DiseaseTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem CellsWhole-Body IrradiationBone and BonesTransplantation ConditioningStem Cell TransplantationGraft SurvivalAnemia, AplasticTissue DonorsLeukemiaKidney TransplantationTransplantation ChimeraLiver TransplantationBusulfanHistocompatibility TestingBone Marrow PurgingHistocompatibilityTransplantation, IsogeneicGraft RejectionCyclophosphamideHematopoiesisImmunosuppressive AgentsMice, Inbred C57BLBone Marrow DiseasesRecurrenceTreatment OutcomeCell DifferentiationTime FactorsCombined Modality TherapyHeart TransplantationRadiation ChimeraLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHematologic NeoplasmsLeukemia, Myeloid, AcuteEmbryonic Stem CellsTransplantation ImmunologyImmunosuppressionBone Marrow ExaminationRemission InductionAdult Stem CellsPrecursor Cell Lymphoblastic Leukemia-LymphomaHepatic Veno-Occlusive DiseaseLung TransplantationBone RemodelingColony-Forming Units AssayLeukemia, MyeloidRetrospective StudiesAcute DiseaseBone Marrow NeoplasmsLymphocyte DepletionGraft vs Host ReactionCyclosporineMesenchymal Stem Cell TransplantationLymphoma, Non-HodgkinChimeraLeukocyte TransfusionSurvival AnalysisHLA AntigensT-LymphocytesSevere Combined ImmunodeficiencyCells, CulturedMyelodysplastic SyndromesPluripotent Stem CellsHematologic DiseasesCytomegalovirus InfectionsFlow CytometryStem Cell NicheCell LineageMesenchymal Stromal CellsActuarial AnalysisFollow-Up StudiesLymphocyte TransfusionTransplantationAntineoplastic Combined Chemotherapy ProtocolsAntigens, CD34Survival RateBone DensityHematopoietic Stem Cell MobilizationGranulocyte Colony-Stimulating FactorNuclear FamilyTransplantsPeripheral Blood Stem Cell TransplantationCarmustineCord Blood Stem Cell TransplantationGraft vs Tumor EffectGraft vs Leukemia EffectCell SeparationMelphalanStem Cell FactorCytarabinePancytopeniaMice, Inbred BALB CLeukocyte Count